Scots are marching for funds to operationalise the access of a life-saving heart treatment, transcatheter aortic valve implantation (Tavi), for patients suffering from aortic stenosis. Even though the Royal Infirmary of Edinburgh and the Golden Jubilee National Hospital in Clydebank are said to have the desired faculties and profound knowledge, they are forced to turn down the patients due to lack of funding.

Nonetheless, European are privileged enough to have affordable access to this treatment, there is not even a single TAVI centre being funded by the NHS in Scotland.

Deciphering the crippling health care situation, the Scottish Cardiac Society (SRC) made a loud appeal to the Scottish government and even sent a written demand letter to the Health Secretary, Nicola Sturgeon, saying "unequivocally confirmed the efficacy of Tavi as a treatment for severe aortic stenosis".

Apparently, another report in March by the Scottish Health Technologies Group, which assesses new technologies for use by the NHS, had reinforced the claims made by the SRC now. The report concluded, “This is currently limited evidence of long-term clinical efficacy, and insufficient information to reliably estimate the cost effectiveness of Tavi".

With the sudden upsurge in dissatisfaction in Scotland, Ms. Sturgeon admitted laxity in the evidence produced in the Tavi review and further, assured for extended review to be done by a team of experts in Scotland